Showing results 6 to 6 of 6
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
Weight loss, cardiovascular diseases and all-cause mortality of overweight/obese patients with type 2 diabetes mellitus initiating sodium glucose co-transporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1A) Proceeding/Conference:International Congress on Obesity and Metabolic Syndrome & Asia-Oceania Conference on Obesity (ICOMES & AOCO), 2019 | 2019 |